AtaiBeckley publishes phase 2a data for depression treatment BPL-003

March 17, 2026 6:00 AM

AtaiBeckley Inc. (NASDAQ: ATAI) published results from its Phase 2a study of BPL-003, an intranasal depression treatment, in the Journal ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found